AIMC Topic: Drug Discovery

Clear Filters Showing 861 to 870 of 1559 articles

Scaffold-Constrained Molecular Generation.

Journal of chemical information and modeling
One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without...

Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.

Medicinal research reviews
Neurological disorders significantly outnumber diseases in other therapeutic areas. However, developing drugs for central nervous system (CNS) disorders remains the most challenging area in drug discovery, accompanied with the long timelines and high...

Advanced machine-learning techniques in drug discovery.

Drug discovery today
The popularity of machine learning (ML) across drug discovery continues to grow, yielding impressive results. As their use increases, so do their limitations become apparent. Such limitations include their need for big data, sparsity in data, and the...

Innovative approaches in CNS drug discovery.

Therapie
Central nervous system disorders remain the leading causes of mortality and morbidity worldwide, affecting more than 1 billion patients. This therapeutic area suffers from high unmet medical needs and the search for innovative approaches to identify ...

Analysis of Biological Screening Compounds with Single- or Multi-Target Activity via Diagnostic Machine Learning.

Biomolecules
Predicting compounds with single- and multi-target activity and exploring origins of compound specificity and promiscuity is of high interest for chemical biology and drug discovery. We present a large-scale analysis of compound promiscuity including...

Moving targets in drug discovery.

Scientific reports
Drug Discovery is a lengthy and costly process and has faced a period of declining productivity within the last two decades resulting in increasing importance of integrative data-driven approaches. In this paper, data mining and integration is levera...

DeepSIBA: chemical structure-based inference of biological alterations using deep learning.

Molecular omics
Predicting whether a chemical structure leads to a desired or adverse biological effect can have a significant impact for in silico drug discovery. In this study, we developed a deep learning model where compound structures are represented as graphs ...

Machine Learning Methods in Drug Discovery.

Molecules (Basel, Switzerland)
The advancements of information technology and related processing techniques have created a fertile base for progress in many scientific fields and industries. In the fields of drug discovery and development, machine learning techniques have been use...